Targacept's Series B Round

Targacept raised a round of funding on March 18, 2003.

Targacept is a biopharmaceutical company advancing NNR Therapeutics for the treatment of various diseases and disorders. The company's NNR Therapeutics selectively target neuronal nicotinic receptors,…

Articles about Targacept's Series B Round: